Cornell researchers developed a new way to safely heat up specific areas inside the body by using biodegradable polymers that contain tiny water pockets, a technology that could lead to precise and noninvasive diagnostics and therapeutics.
Tirzepatide (trade name Zepbound) promoted greater weight loss in individuals with obesity than semaglutide (trade name Wegovy) in a clinical trial that compared the safety and efficacy of the injectable drugs.
In this episode of the Inclusive Excellence Podcast, co-hosts Erin Sember-Chase and Toral Patel are joined by Julie Edwards, assistant vice president of student and campus life for student health and wellbeing, for a conversation on how Cornell is prioritizing the creation of a health-promoting campus.
Teams of health care providers called Accountable Care Organizations participating in the Medicare Shared Savings Program have saved Medicare between $4.1 billion and $8.1 billion from 2012–2019, according to a new study from Weill Cornell Medicine investigators.
A study from Cornell researchers could enable a quantum leap forward in identifying and deciphering cancer-driving genetic mutations, the first step in developing effective therapeutics.
Weill Cornell Medicine researchers found that restricting telehealth prescriptions for opioid use disorder could keep thousands from accessing buprenorphine, a medication that helps people recover from addiction.
The modification commonly found on messenger RNAs plays a surprisingly large role in how cells respond to stress, according to a study led by Weill Cornell Medicine investigators.
Knocking out a single gene reprograms part of the large intestine to function like the nutrient-absorbing small intestine; Weill Cornell investigators showed that this reversed the malnutrition that results when most of the small intestine is removed.
Implemented by Cornell Cooperative Extension and partners, SNAP-Ed New York helped hundreds of thousands of low-income New Yorkers improve their diet and overall health every year.